![]() |
We are working with The Sage Group to help us find partners to use our biomarker discovery platform to develop more predictive autoantibody marker panels. (For more details see our press release.) Please email Dr. Bill Mason at The Sage Group if you would like to recive a presentation outlining the technology or to discuss your proposed programme in more depth. Alternatively, please contact us direct if you would prefer. Collaborations may involve:
The technology is best suited to the discovery of biomarker panels for cancer and autoantibody diseases. |